UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study

Supportive care in cancer, 2019-08, Vol.27 (8), p.3035-3043

2019

Volltextzugriff (PDF)

Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study

Breast cancer research and treatment, 2018-10, Vol.171 (3), p.709-717

2018

Volltextzugriff (PDF)

Ataxia-telangiectasia gene ( ATM ) mutation heterozygosity in breast cancer: a narrative review

Current oncology (Toronto), 2018-04, Vol.25 (2), p.e176-180

2018

Volltextzugriff (PDF)

A population-based analysis of breast cancer incidence and survival by subtype in Ontario women

Current oncology (Toronto), 2020-04, Vol.27 (2), p.e191-198

2020

Volltextzugriff (PDF)

Willingness of Women with Early Estrogen Receptor–Positive Breast Cancer to Take Adjuvant CDK4/6 Inhibitors

Current oncology (Toronto), 2020-06, Vol.27 (3), p.127-134

2020

Volltextzugriff (PDF)

Cetuximab (Cmab) plus irinotecan (I) versus panitumumab (Pmab) in patients with refractory metastatic colorectal cancer (mCRC) in Ontario

Annals of oncology, 2016-10, Vol.27, p.vi163-vi163

2016

Volltextzugriff (PDF)

Abstract P3-08-12: Prognostic relevance of neutrophil-to-lymphocyte ratio (NLR) in young women with breast cancer (BC)

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P3-P3-08-12

2018

Volltextzugriff (PDF)

Abstract PD6-05: A prospective evaluation of clinical outcomes in women with pregnancy-associated breast cancer (PABC)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.PD6-05-PD6-05

2017

Volltextzugriff (PDF)

Abstract P3-08-08: Prognostic associations of plasma hepcidin in early breast cancer (BC)

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P3-P3-08-08

2018

Volltextzugriff (PDF)

Abstract OT1-12-01: Exploration of factors associated with imminent risk of late recurrence in hormone receptor positive breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT1-12-01-OT1-12-01

2019

Volltextzugriff (PDF)

The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis

Neuro-oncology (Charlottesville, Va.), 2021-06, Vol.23 (6), p.894-904

2021

Volltextzugriff (PDF)

Impact of Location of Residence and Distance to Cancer Centre on Medical Oncology Consultation and Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer

Current oncology (Toronto), 2024-08, Vol.31 (8), p.4728-4745

2024

Volltextzugriff (PDF)

Intracranial Metastatic Disease: Present Challenges, Future Opportunities

Frontiers in oncology, 2022-03, Vol.12, p.855182-855182

2022

Volltextzugriff (PDF)

The incidence of bone metastasis after early-stage breast cancer in Canada

Breast cancer research and treatment, 2016-04, Vol.156 (3), p.587-595

2016

Volltextzugriff (PDF)

2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients

Supportive care in cancer, 2024-05, Vol.32 (5), p.280-280, Article 280

2024

Volltextzugriff (PDF)

Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome

European journal of cancer (1990), 2021-09, Vol.155, p.13-24

2021

Volltextzugriff (PDF)

Central Nervous System-Specific Outcomes of Phase 3 Randomized Clinical Trials in Patients With Advanced Breast Cancer, Lung Cancer, and Melanoma

JAMA oncology, 2021-07, Vol.7 (7), p.1062

2021

Volltextzugriff (PDF)

Abstract OT1-07-01: MRI screening versus symptom-directed surveillance for brain metastases among patients with triple negative or HER2+ metastatic breast cancer: A pilot study (nct03881605)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT1-07-01-OT1-07-01

2022

Volltextzugriff (PDF)

Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications

Breast cancer research and treatment, 2015-01, Vol.149 (1), p.293-301

2015

Volltextzugriff (PDF)

Stereotactic Body Radiotherapy (SBRT) for Breast Cancer Spinal Metastases is Associated with Low Rates of Long-Term Local Failure (LF) and Vertebral Compression Fracture (VCF) Independent of Molecular Status

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e153-e153

2023

Volltextzugriff (PDF)

Evaluation of the impact of patient involvement in health technology assessments: A scoping review

International journal of technology assessment in health care, 2020-06, Vol.36 (3), p.217-223

2020

Volltextzugriff (PDF)

Assessing the Association of Targeted Therapy and Intracranial Metastatic Disease

JAMA oncology, 2021-08, Vol.7 (8), p.1220

2021

Volltextzugriff (PDF)

Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period

Data in brief, 2021-10, Vol.38, p.107354-107354, Article 107354

2021

Volltextzugriff (PDF)

Cetuximab plus irinotecan versus panitumumab in patients with refractory metastatic colorectal cancer in Ontario, Canada

International journal of cancer, 2017-05, Vol.140 (9), p.2162-2167

2017

Volltextzugriff (PDF)

T-DM1 Increases the Risk of SRS-Induced Radiation Necrosis in Her2+ Breast Cancer

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e568-e568

2021

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study

Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study

Ataxia-telangiectasia gene ( ATM ) mutation heterozygosity in breast cancer: a narrative review

A population-based analysis of breast cancer incidence and survival by subtype in Ontario women

Willingness of Women with Early Estrogen Receptor–Positive Breast Cancer to Take Adjuvant CDK4/6 Inhibitors

Cetuximab (Cmab) plus irinotecan (I) versus panitumumab (Pmab) in patients with refractory metastatic colorectal cancer (mCRC) in Ontario

Abstract P3-08-12: Prognostic relevance of neutrophil-to-lymphocyte ratio (NLR) in young women with breast cancer (BC)

Abstract PD6-05: A prospective evaluation of clinical outcomes in women with pregnancy-associated breast cancer (PABC)

Abstract P3-08-08: Prognostic associations of plasma hepcidin in early breast cancer (BC)

Abstract OT1-12-01: Exploration of factors associated with imminent risk of late recurrence in hormone receptor positive breast cancer

The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis

Impact of Location of Residence and Distance to Cancer Centre on Medical Oncology Consultation and Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer

Intracranial Metastatic Disease: Present Challenges, Future Opportunities

The incidence of bone metastasis after early-stage breast cancer in Canada

2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients

Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome

Central Nervous System-Specific Outcomes of Phase 3 Randomized Clinical Trials in Patients With Advanced Breast Cancer, Lung Cancer, and Melanoma

Abstract OT1-07-01: MRI screening versus symptom-directed surveillance for brain metastases among patients with triple negative or HER2+ metastatic breast cancer: A pilot study (nct03881605)

Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications

Stereotactic Body Radiotherapy (SBRT) for Breast Cancer Spinal Metastases is Associated with Low Rates of Long-Term Local Failure (LF) and Vertebral Compression Fracture (VCF) Independent of Molecular Status

Evaluation of the impact of patient involvement in health technology assessments: A scoping review

Assessing the Association of Targeted Therapy and Intracranial Metastatic Disease

Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period

Cetuximab plus irinotecan versus panitumumab in patients with refractory metastatic colorectal cancer in Ontario, Canada

T-DM1 Increases the Risk of SRS-Induced Radiation Necrosis in Her2+ Breast Cancer

Suchergebnisse filtern